Trial
NCT05781750
A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Kezar Life Sciences, Inc.
Collaborators
—
Condition
Lupus Nephritis
Intervention
zetomipzomib
Why stopped
Sponsor Decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-05